Cedar Grove Residential Treatment Facility

Cedar Grove Residential Treatment Facility (Memphis, TN) is a SAMHSA Behavioral Health Treatment Services Locator-registered facility. The specific care levels offered by Cedar Grove Residential Treatment Facility should be confirmed directly with the admissions team. Evaluation of this facility against current clinical standards should encompass ASAM 4e framework alignment, MAT policy, and payer-specific network status.

Care levels at Cedar Grove Residential Treatment Facility

Care-level specifics for Cedar Grove Residential Treatment Facility are not well-documented in the public SAMHSA record; a direct conversation with the admissions team is the reliable way to confirm what the facility actually provides. ASAM Criteria 4e level-of-care matching requires clinical assessment across six dimensions (withdrawal potential, biomedical conditions, emotional/behavioral/cognitive conditions, readiness, relapse risk, recovery environment). The alignment of Cedar Grove Residential Treatment Facility's offerings to any specific patient's clinical profile should be determined by an independent ASAM-aligned assessment prior to admission.

Insurance and payment

Payment and insurance specifics for Cedar Grove Residential Treatment Facility are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. Benefit verification should be obtained in writing prior to admission and should document: network contract status for the specific insurance product, prior authorization requirements and approved day-count, applicable cost-sharing structure, and out-of-network secondary coverage (where applicable). Proceeding on verbal VOB creates material risk of post-admission benefit dispute.

Before you call

Pre-admission due-diligence for Cedar Grove Residential Treatment Facility: (1) ASAM 4e level-of-care documentation matching clinical assessment; (2) written Verification of Benefits specific to insurance product; (3) MAT policy documentation (particularly buprenorphine and methadone continuation protocols for opioid use disorder patients); (4) accreditation verification via CARF or Joint Commission provider-search tools; (5) state licensing status confirmed via TN behavioral-health regulator inspection records. If the clinical situation involves opioid use disorder, confirm explicitly whether Cedar Grove Residential Treatment Facility offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.